The United States cannabidiol landscape has come a long way since researchers first isolated cannabidiol in the early 1940s, but real momentum only picked up during the 2010s when stories like that of Charlotte Figi and the Stanley brothers strain known as “Charlotte’s Web” drew national attention for reducing seizures in children with Dravet syndrome. In 2018 the passage of the Agriculture Improvement Act (Farm Bill) reclassified hemp, defined as Cannabis sativa with no more than 0.3% delta‑9 THC, under federal law so it is no longer a Schedule I substance, thus allowing hemp‑derived extracts to be produced and transported across state lines under USDA oversight. But the U.S. Food and Drug Administration still maintains that no CBD product may be added to foods or marketed as a dietary supplement under current rules, even while it has approved one pharmaceutical, Epidiolex, made by GW Pharmaceuticals for rare epileptic disorders. Extraction techniques have become far more sophisticated, companies now routinely use supercritical carbon dioxide extraction and ethanol extraction to produce broad spectrum, full spectrum, or isolate forms of the compound depending on whether residual plant compounds (terpenes, flavonoids) are to be retained. Brands like Joy Organics in Fort Collins, Colorado have emphasized USDA organic certification and third‑party lab testing.

Packaging has shifted too, child‑resistant glass droppers, tamper‑evident seals, QR codes to verify lab results are now common. Safety concerns have prompted studies, for example from Virginia Commonwealth University which found some products with heavy metal or pesticide contamination, raising demand for transparency. Regulatory delays such as FDA’s requirement to issue public hearing and comments in 2019 to gather safety data from thousands of submissions have slowed some food and beverage manufacturers. According to the research report, "United States Cannabidiol Market Research Report, 2030," published by Actual Market Research, the United States Cannabidiol market is anticipated to grow at more than 14.83% CAGR from 2025 to 2030. The U.S. cannabidiol market has experienced marked competition and diversification since the federal hemp reclassification. Major players like Charlotte’s Web, Joy Organics, CV Sciences, and Medterra have increasingly occupied shelves in drugstores like CVS and Walgreens, while startups have launched direct‑to‑consumer brands via Shopify and other platforms. E‑commerce has been a critical channel, many purchases are made through online sites, social media advertising and influencer endorsements rather than traditional display‑based ads. Physical retail remains strong in specialty wellness boutiques, regional health food stores and pharmacies in metropolitan hubs such as Los Angeles, New York City and Miami.

FDA and Federal Trade Commission have issued warning letters to companies making unverified therapeutic claims, and online platforms like Facebook and Google limit CBD‑related ad content. Supply chain challenges include difficulties sourcing compliant hemp biomass, ensuring consistency among batches, and managing interstate shipping regulations federal rules vary in enforcement and state law sometimes conflicts. In response, innovations have arisen such as nanoemulsion delivery formats for faster absorption, broad‑spectrum formulations that remove virtually all THC, and extensive use of third‑party labs like Eurofins or Covance to certify potency and safety. Consumers increasingly demand products with transparent origin stories, organic farming practices, non‑psychoactive compositions and sustainable packaging. Despite saturation in many CBD‑oil lines, new product forms (topicals, pet products, infused drinks) are emerging. Also notable are partnerships between drug companies and wellness brands, like GW Pharma’s further research programs, which lend scientific credibility.In the United States, oils and tinctures are among the most widely used forms of cannabidiol, particularly in states such as Colorado, California, and Oregon where the hemp industry is well established.

Companies based in Boulder and Denver continue to offer full-spectrum and broad-spectrum CBD oils that are absorbed under the tongue and used daily by individuals seeking natural support for anxiety, inflammation, or sleep. Capsules and softgels are increasingly favored in states like Texas, Florida, and Illinois, where consumers prefer pre-measured formats that are easy to swallow and fit into vitamin routines. These are often packaged alongside multivitamins and sold through health-focused retailers. Gummies and confectionery products are especially popular in cities like Los Angeles, Austin, and Atlanta, offering a flavored alternative that appeals to younger adults and first-time users. These CBD-infused treats come in a variety of forms such as fruit chews, chocolates, and caramels. Topicals and skincare products, including creams, balms, and massage oils, are often purchased in urban wellness communities like Brooklyn and Portland where people seek relief from joint pain, muscle soreness, and skin conditions without ingesting cannabinoids.

Vape products are mostly concentrated in areas with relaxed cannabis laws such as San Diego, Seattle, and Las Vegas, where consumers inhale CBD using cartridge pens or refillable devices for fast onset effects. Although the vape segment faces strict regulation in certain states, it remains active in adult-use cannabis markets. Other formats include dissolvable powder packets, oral sprays, and transdermal patches, often sold in boutique shops or online by companies based in California and North Carolina. In the United States, wellness and personal use is the most common reason for CBD consumption, particularly in cities like Los Angeles, Miami, and Chicago where yoga studios, wellness centers, and natural food stores promote CBD as part of daily self-care routines. Individuals use it to manage stress, support sleep, or promote recovery after exercise. In the nutraceutical and supplement space, CBD is often taken alongside turmeric, melatonin, or magnesium in states like Arizona, Georgia, and Washington where health supplements usage is widespread.

These formulations are available in pill, capsule, or softgel formats and appeal to consumers focused on preventive health and long-term wellness. Pet care has become a fast-growing segment in regions like Texas, Colorado, and Pennsylvania, where dog and cat owners purchase CBD-infused treats and oils to help animals with anxiety during storms, car rides, or separation from owners. Veterinary clinics in some cities carry pet-safe CBD formulations that are free of THC. Cosmetics and skincare applications are expanding in fashion-forward markets such as Manhattan, Beverly Hills, and Scottsdale where consumers purchase CBD serums, eye creams, bath bombs, and lotions to support skin hydration, reduce redness, or soothe irritation. In the pharmaceutical space, CBD is dispensed under prescription in the form of Epidiolex, which is used to treat rare seizure disorders such as Dravet syndrome and is available through licensed pharmacies in states like New York, Massachusetts, and California. In the food and beverage category, CBD is used in sparkling waters, protein bars, and cold brew coffees sold in wellness cafés and boutique grocery stores in places like Portland, Austin, and Denver.

In the United States, marijuana-derived CBD is sourced from cannabis plants that contain more than 0.3% THC and is only legal in certain states such as California, Oregon, and Colorado where adult-use cannabis is regulated by state law. This type of CBD is typically extracted from the same plants used to produce recreational marijuana and is sold in dispensaries in cities like San Diego, Boulder, and Portland. It is often used by patients or consumers seeking high-potency formulations or full-spectrum extracts with a balanced cannabinoid profile. Hemp-derived CBD comes from federally legal hemp plants and is grown on farms in states like Kentucky, North Carolina, and Tennessee where the climate and soil conditions support large-scale cultivation. Farmers in these states grow hemp specifically for extraction, and the CBD is processed in facilities located near Lexington, Asheville, and Nashville. Hemp-derived CBD is permitted for sale in most U.S. states as long as the THC content remains below federal limits.

This source supports the majority of over-the-counter CBD products such as oils, edibles, and cosmetics sold in grocery stores, pharmacies, and online. Unlike marijuana-derived CBD, hemp CBD can be shipped across state lines and is used in both wellness and commercial food products. States like Colorado and Vermont have established detailed hemp programs that require growers to test for THC compliance and follow organic practices, making hemp a dominant source for nationwide brands. Some states like South Dakota and Idaho limit even hemp-derived CBD based on local regulations, creating uneven access depending on geography.  Considered in this report• Historic Year: 2019• Base year: 2024• Estimated year: 2025• Forecast year: 2030Aspects covered in this report• Cannabidiol Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Form• Oils & Tinctures• Capsules & Softgels• Gummies & Confectionery• Topicals / Skin Care• Vape Products• OthersBy End Use• Wellness & Personal Use• Nutraceuticals & Supplements• Pet Care• Cosmetics & Skin Care• Pharmaceuticals• Food & BeveragesBy Source• Marijuana• Hemp.